Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TRI-LO-MILI TABLET

Norgestimate and Ethinyl Estradiol
$0.1102per EA

Manufacturer

Aurobindo Pharma Limited

NDC

65862077885

Classification

Generic

Dosage Form

KIT

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205762

On Market Since

11/4/2016

Price History

1W

0.0%

1M

-0.6%

3M

-2.2%

6M

-1.4%

1Y

-4.1%

3Y

-25.7%

5Y

-35.5%

All

-52.4%

Generic Alternatives

7 alternatives • Same active ingredient

TRI-VYLIBRA LO TABLET
Generic
50102023113•Afaxys Pharma, LLC
$0.1102
TRI-LO-SPRINTEC TABLET
Generic
00093214062•Teva Pharmaceuticals USA Inc.
$0.1102
TRI-LO-MILI TABLET
Generic
65862077828•Aurobindo Pharma Limited
$0.1102
NORG-ETHIN ESTRA 0.25-0.035 MG
Generic
68180084073•Lupin Pharmaceuticals Inc.
$0.1260
+14% more
NORG-ETHIN ESTRA 0.25-0.035 MG
Generic
68462030929•Glenmark Pharmaceuticals Inc., USA
$0.1260
+14% more
TRI-LINYAH TABLET
Generic
16714036301•NorthStar Rx LLC
$0.1332
+21% more
TRI-NYMYO 28 TABLET
Generic
51862064606•Mayne Pharma
$0.1373
+25% more

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy